This invention discloses a novel intelligent rapid screening device for depression / Alzheimer's
disease, used for early auxiliary detection of either condition. It comprises: an EEG acquisition module, a human-computer interaction module, a
wireless transmission module, and an intelligent analysis module. The EEG acquisition module collects resting-state and task-oriented EEG signals from the subject. The human-computer interaction module selects the screening mode, inputs subject information, performs impedance detection,
signal verification, and provides task guidance. The
wireless transmission module enables
data transmission between the modules. The intelligent analysis module receives the EEG signals, analyzes the data using a
machine learning model, and outputs the screening results. This device uses dry
electrode technology, eliminating the need for conductive
adhesive. The brain-computer interface is made of
skin-friendly material for comfortable wear.
Wireless transmission and cloud analysis provide high flexibility. AI-based
data analysis and
pattern recognition improve diagnostic efficiency and accuracy.